Clinical Trial Detail

NCT ID NCT02599454
Title Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, Davis
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab

Age Groups: adult

No variant requirements are available.